Immuneering Corp. (IMRX)
4.99
0.00 (0.00%)
USD |
NASDAQ |
Feb 27, 16:00
4.82
-0.17
(-3.41%)
After-Hours: 04:35
Immuneering Research and Development Expense (TTM) : 47.41M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 109.27M |
| Verastem, Inc. | 103.74M |
| Phathom Pharmaceuticals, Inc. | 32.78M |
| Tango Therapeutics, Inc. | 132.82M |
| Moderna, Inc. | 2.917B |